Market
Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook
Zimmer Biomet reported 4.8% year-over-year revenue growth in Q2 and raised its 2026 financial outlook, driving a 5% share price increase at NYSE opening on August 5. The earnings beat reflects demand across the company's orthopedics, spine, and specialty surgical portfolios.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network